Zijie Su
-
- Cancer-related molecular mechanisms research 3
- Biotechnology top 10%
-
- Wnt/β-catenin signaling in development and cancer 14
- Cancer-related gene regulation 8
- Circular RNAs in diseases 4
- Ubiquitin and proteasome pathways 3
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Pharmacology top 10%
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Desheng LuQi SunJiaxing SongZhongyuan WangLiang ZhouShubin YuDennis A. CarsonYun Zeng
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Angewandte Chemie International Edition (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Zijie Su
41 papers receiving 702 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 141
- Biotechnology 77
- Molecular Biology 411
- Applied Microbiology and Biotechnology 12
- Pharmacology 51
Countries citing papers authored by Zijie Su
This map shows the geographic impact of Zijie Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zijie Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zijie Su more than expected).
Fields of papers citing papers by Zijie Su
This network shows the impact of papers produced by Zijie Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zijie Su. The network helps show where Zijie Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zijie Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 24 | |
| 14 | 2021 | 22 | |
| 15 | 2020 | 19 | |
| 16 | 2020 | 9 | |
| 17 | 2017 | 5 | |
| 18 | 2014 | 1 | |
| 19 | 2011 | 27 | |
| 20 | 2009 | 40 |
About Zijie Su
Zijie Su is a scholar working on Applied Microbiology and Biotechnology, Molecular Biology and Cancer Research, having authored 44 papers that have together received 708 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (14 papers), Cancer-related gene regulation (8 papers), Circular RNAs in diseases (4 papers), Ferroptosis and cancer prognosis (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related molecular mechanisms research (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (141 citations), Biotechnology (77 citations) and Molecular Biology (411 citations). Zijie Su has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Desheng Lu, Qi Sun, Jiaxing Song, Zhongyuan Wang, Liang Zhou, Shubin Yu, Dennis A. Carson, Yun Zeng, Ou Sha and Bo Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.